U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

LENRISPODUN

MORE DETAILS

3GBO34D1BE

Status:
Investigational
Source:
NCT03387215: Phase 1/Phase 2 Interventional Completed Heart Failure, Systolic
(2018)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03387215
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Phosphodiesterase 3B
8
Phosphodiesterase 1B
2
Phosphodiesterase 1A
2
Phosphodiesterase 1C
2
Phosphodiesterase 4D
14

LENRISPODUN PHOSPHATE

MORE DETAILS

YP683YZB8K

Status:
Investigational
Source:
NCT03387215: Phase 1/Phase 2 Interventional Completed Heart Failure, Systolic
(2018)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03387215
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Phosphodiesterase 3B
8
Phosphodiesterase 1B
2
Phosphodiesterase 1A
2
Phosphodiesterase 1C
2
Phosphodiesterase 4D
14
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966